Results 211 to 220 of about 164,447 (333)

Genetic and clinical features of microcephaly in a prenatal cohort. [PDF]

open access: yesBMC Pregnancy Childbirth
Zhang Y   +9 more
europepmc   +1 more source

Cardiovascular phenotypes of children and adolescents with Turner syndrome from a single-center cohort study. [PDF]

open access: yesOrphanet J Rare Dis
Hu F   +10 more
europepmc   +1 more source

Limited diagnostic value of lymphocytic karyotype in primary amenorrhea with streak gonads

open access: bronze, 1987
N Surico   +6 more
openalex   +1 more source

Comorbidities and mutations including single‐ and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population‐based study

open access: yesBritish Journal of Haematology, EarlyView.
In a population‐based cohort of 149 chronic myelomonocytic leukaemia (CMML) patients, multihit TET2 mutation was associated with older age, lower LDH and less leucocytosis. We found no association with autoimmune disease or thrombosis. Patients with multihit TET2 mutation had a significantly longer overall survival than the patients without or with one
Matilda Kjellander Kynning   +14 more
wiley   +1 more source

Single sperm karyotyping of testicular sperm in non-obstructive and obstructive azoospermia using next generation sequencing. [PDF]

open access: yesPLoS One
Sueyoshi S   +23 more
europepmc   +1 more source

Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. [PDF]

open access: yesCancer
Yasin I   +27 more
europepmc   +1 more source

Hypomethylating agents in vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review

open access: yesBritish Journal of Haematology, EarlyView.
Summary VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) is an X‐linked, systemic, haemato‐inflammatory syndrome caused by somatic mutations in the UBA1 gene. No standardized treatment guidelines exist, but evidence is emerging that treatment with hypomethylating agents (HMAs) can induce improvement of the inflammatory symptoms,
Fieke W. Hoff   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy